Electromedical and X-ray Equipment Market Research Report - Industry Analysis and Forecas to 2024 | Hexa Research

X-beam is a kind of electromagnetic ionizing radiation with applications in a broadened scope of businesses. In therapeutic industry, X-beam gadgets constitute the biggest offer of the symptomatic imaging market. The maturing of the world's population and the rising occurrence of growth, coronary illness, and different conditions is driving the demand for electromedical and X-ray equipment market for cancer, heart disease, and X-rat gadgets. Interest is driven by mechanical progressions, demographics (the maturing US populace drives the requirement for medicinal items), and the necessities of the human services industry. The profitability of individual organizations relies on upon operations and viable advertising. Vast organizations appreciate economies of scale in examination, assembling, advertising, and conveyance. Littler organizations can contend adequately by creating inventive advancements or claim to fame items for corner markets, for example, growth treatment device.

Browse Details of Report@

https://www.hexaresearch.com/upcoming-research/electromedical-x-ray-equipment-market

Accessibility of substantial number of players in the business sector has led to a nonstop evolvement of cutting edge advances to build image quality. Advanced imaging procedures keep on evolving with enhancements in picture quality, measurement lessening systems, and efficiencies in work process. The X-ray gadgets innovation has moved from simple imaging to advance. X-rays show numerous applications in the diagnostic as well as therapeutic areas of cancer, cardiovascular and mid-section illnesses to give some examples. Fast advances in radiology that have happened in the previous couple of decades have made ready for the extension of the medicinal imaging hardware market. Imaging gadgets, for example, magnetic resonance imaging (MRI), computed tomography (CT or CAT), and ultrasound have permitted further choices for treatment direction with low dismalness. This has helped doctors to evaluate patients without surgical mediation and along these lines enhance the patient results and personal satisfaction

X-ray imaging gadgets constituted the key fragmenst in the worldwide medical imaging equipment market. The key driving forces for the development of this segment includes expanding occurrence of scatters and simple accessibility and adequacy of x-ray gadgets. Rising occurrence of cardiovascular, respiratory, oral, gastrointestinal, and genitourinary scatters are boosting dependence on a few propelled x-beam indicative gadgets all around. The WHO gauges that around 60% to 90% of school kids and 80% to 90% grown-ups (matured 19 to 34 years) experience the ill effects of dental cavities. In addition, the worldwide rate of oral growth ranges between 1-10 cases for every 100,000 people. These two variables, combined with an expansive patient pool of patients experiencing dental pits, is expected to boost the industry growth. Among the x-ray gadgets market, stationary gadgets overwhelmed the business sector by ideals of being routinely utilized imaging gadgets. These are likewise a more financially savvy choice contrasted with compact x-beam hardware gadgets. Stationary gadgets are for the most part favored in the underserved markets of Asia and Africa.

Based on product type, the Electromedical and X-ray Equipment Market is segmented into Digital Radiography (DR), Computed Radiography (CR) and retrofit radiography system. Electro-medical equipment includes a variety of powered devices, such as pacemakers, patient-monitoring systems, MRI machines, diagnostic imaging equipment (including informatics equipment), and ultrasonic scanning devices.

Established markets such as the US, Western Europe, and Japan are top sales regions for the industry. Developing nations such as Brazil, Russia, India, and China are targeted by companies in the industry for growth.

Major US companies include Medtronic,Hologic, Varian Medical Systems,, St Jude Medical and ZollMedical, as well as  General Electric. Outside the US, major companies includeSonova (Switzerland), St Jude Medical,, St Jude Medical., Bracco Imaging S.p.A, , Agfa-Gevaert N.V ,Canon, Inc., Fujifilm Holdings Corporation,,Agfa-Gevaert N.V, Hologic, Inc., Hitachi Medical Corporation, Konica Minolta, Inc., Shimadzu Corporation,, Agfa-Gevaert N.V., Philips Healthcare, , Agfa-Gevaert N.V , Thales group,, Agfa-Gevaert N.V, Varian Medical Systems, Inc., , Agfa-Gevaert N.V  and Ziehm Imaging, Inc.

Browse Related Category Market Reports @

https://www.hexaresearch.com/research-category/medical-imaging-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin: https://www.linkedin.com/company/hexa-research

Legionella Testing Market Research Report - Global Industry Analysis and Forecas to 2020 | Hexa Research

The global legionella testing market is expected to grow at a considerable rate over the forecast period owing to the advancements and automation in the immunodiagnostic market such as the introduction of advanced ELISA antibodies for the prevention of legionnaires diseases in the market. The rapidly rising awareness about legionella based diseases and the increase in demand for advanced immunodiagnostic techniques is a direct consequence of rapidly increasing incidences of mild flu and pneumonia like diseases through legionella bacteria. Since legionella bacteria requires the presence of iron and cysteine to grow, it is traditionally detected by culture on buffered charcoal yeast extract. This process takes 4 to 5 days for detecting the legionella bacteria. The advanced immunological techniques such as polymerase chain reaction and rapid immunological assays are efficient to detect the legionella bacteria in few minutes. These techniques are commonly used to establish the presence of species of Legionella bacteria in the sample. Some of the other drivers for the growth of the global legionella testing market include the entry of new players, new emerging economies such as China and India and increase in the funding for healthcare facilities by the government in many regions. There are about 40 different species of legionella bacteria out of which 18 species are infectious. Among all these species, the legionella pneumophilla bacterium can cause most of the diseases. Many hospitals have started various tests such as legionella urinary antigen test for the initial detection of legionella based diseases. This is the factor expected to further fuel the legionella testing market over the forecast period.

Browse Details of Report @ https://www.hexaresearch.com/upcoming-research/legionella-testing-industry

The legionella testing market has been divided on the basis of antibiotics used for the treatment of legionella infections into rifampin, azithromycin, ketolides, quinolones and macrolides. It is expected that Azithromycin drug will grow at the fastest rate throughout the forecast period owing to its efficiency to treat legionella based diseases. Azithromycin drug is mainly used for treating this infection in children and adults. The increasing incidences of legionella based diseases in children and adults is also a factor driving the Azithromycin drug segment in the market. Apart, certain flouroquinolones such as moxifloxacin and levofloxacin are also considered as the most efficient drugs for legionella based diseases. There are several diagnostic tests which are available commercially in the market for initial detection of Legionella bacteria in the body such as sputum or lung tissue test, urine antigen test, chest X-ray and blood test. There are various end users of legionella testing drugs which include hospitals, commercial or private labs, physician offices and public health labs.

Major regions estimated for the legionella testing market are North America, Europe, Asia Pacific and RoW. As of 2013, North America dominated the market attributing the largest share in terms of revenue. This large share can be accounted for by the increasing number of patients suffering from legionella based diseases, the presence of large number of market players and government initiatives such as various public health labs across the region. Owing to the new emerging economies such as Germany and U.K. and rising awareness about legionella based diseases in the Europe region, it is expected that this region will show lucrative growth in the global legionella testing market over the forecast period.

The key participants in the legionella testing market include Roche Diagnostics, Beckman Coulter, Bio Rad, Novartis Diagnostics, Life Technology, Becton Dickinson, Abott laboratories, Eiken Chemical, ID Biomedical, Thermo Fischer, Takara Bio, Kreatech, Gen Probe, Enzo Biochem and SeraCare. The market leaders in the global legionella testing market are involved in continuous efforts for the development of innovative methodologies of testing which would increase the efficiency and accuracy of test results while providing the smooth processing of larger samples simultaneously. This companies are also entering into strategic collaborations and expansions to extend their global patient base.

Browse Related Category Market Reports@

https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin: https://www.linkedin.com/company/hexa-research

Glucose Biosensors Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 | Hexa Research

The worldwide glucose biosensors market size is expected to surpass USD 31 billion by 2024. It was valued about USD 15.3 billion in 2015. The high incidence of diabetes is a key factor that drives this market. Technological breakthroughs in monitoring glucose levels can spur market demand. Biosensors are devices that detect biological changes in the body and display those via electronic indicators. These changes (commonly known as analytes) could be gases, organic compounds, bacteria, and others.

Glucose biosensors can sense glucose levels within the body. They are small & minimally invasive devices that assess glucose levels in outpatient settings. Need for reliable biosensors still pose a market challenge. Alternative methods, like laboratory tests can restrict market growth. But several companies are investing in R&D (research and development) to improve the current technology.

Browse Details of Report@ https://www.hexaresearch.com/research-report/glucose-biosensors-market

The global Glucose Biosensors Market is segmented on the basis of types, end-users, and regions. The two types are amprometric and fluorescent. Amperometric biosensors are extensively available. They function by way of glucose oxidase. These devices combine glucose with oxygen to produce hydrogen peroxide. The electrode identifies hydrogen peroxide and accurately measures glucose levels from it.

Fluorescent biosensors are estimated to capture major market shares over the forecast period (2016-2024). These biosensors measure glucose levels by detecting sensitive proteins via the fluorescence process. Better operational life of these devices may benefit the market in the years ahead.

End-users are home care diagnostics, hospitals, and others. Others include diagnostic laboratories, research institutes, and clinical. Home care diagnostics held over 46% market shares in 2015. This segment comprises the adoption hand-held glucose meters. These devices deliver quick & efficient results and reduce the need for frequent hospital visits. ‘Hospitals’ may expand significantly over the next eight years. It could grow a 10.3% CAGR from 2015 to 2022.

Regions in the global Glucose Biosensors Market are North America, Latin America, Middle East & Africa (MEA), Asia Pacific, and Europe. North America dominated the worldwide market with nearly 37% shares in 2015. Growing cases of diabetes coupled with technological advancements in the region can boost revenues during the forecast period. Europe may be the second largest market in terms of revenue after North America.

Asia Pacific is expected to grow at a CAGR of 13% from 2015 to 2022. India & China jointly accounted for over 65% of the global diabetic base in 2013. This could benefit the worldwide market in the years ahead.

Major players in the glucose biosensor industry are LifeScan Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, and Bayer AG. These companies held over 70% of the total market shares in 2014. They focus on product development, partnerships, and collaborations for long term growth and market sustenance. For instance, LifeScan introduced a new glucose monitoring system, OneTouch Verio in 2015. It measures glucose levels via a color-coded indicator.

Mayo Clinic, Gentag, NovioSense, and Fraunhofer Institute for Microelectronic Circuits & Systems entered a collaboration to fight against type 2 diabetes, in 2015. They aim at equipping smartphones with low-cost diabetes monitoring systems. The technology thus developed may be employed in a number of diabetes applications, such as eye sensors, skin patches, long-terms implantable sensors and so on. All of these devices can be controlled via smartphones. Currently, carbon nanotubes are gaining popularity due to their exceptional physical and electrical properties. These nanotubes work well with glucose biosensors by providing support for enzyme control.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin : https://www.linkedin.com/company/hexa-research 

Sterilization Technologies Market Analysis, Size, Share, Growth and Forecast to 2019 | Hexa Research

Sterilization makes sure harmless products for human consumption and commercial processes. Recent regional market development has created the need for effective, swift and cost-effective technologies that ensure safety all through the production process. This report analyzes the key processes of filter, chemical, heat and radiation sterilization. Market trends are analyzed and global market estimates for the manufacturing, pharmaceutical, food & beverage equipment and consumables are provided.

The global market of sterilization capital equipment and filtration consumables was worth USD 3.34 billion in 2010 and USD 3.85 billion in 2011. This market is expected to grow at a CAGR of 7.2% from 2013 to 2019.

Browse Details of Report@ https://www.hexaresearch.com/upcoming-research/sterilization-technologies-industry/

The filter sterilization market segment including equipment and consumables was estimate at USD 2.11 billion in 2011 and is expected to grow at a CAGR of 9.5% from 2013 to 2019. The liquid filtration segment reached USD 1.11 billion in 2010 and USD 1.42 billion in 2011. It is expected to grow at a CAGR of 11.0%. Capital equipment sales for heat sterilization technologies was worth USD 1.10 billion in 2011 and is expected to grow at a CAGR of 3.6% from 2013 to 2019.

This research report provides comprehensive market statistics and forecast for key segments, and provides complete industry landscape including drivers, restraints, regulatory scenario, technology trends and future opportunities. The report also provides detailed competitive landscape with company market share analysis and in-depth profiles of key market participants. Key regional markets analyzed and reported in this study include:

·         North America

·         Europe

·         Asia Pacific

·         RoW

Critical elements of the report include:

·         Industry dynamics

·         Market challenges and opportunities

·         Technology & regulatory trends

·         Market estimate and forecast

·         Regional trends

·         Competitive trends

Why should you buy this report?

·         This report provides comprehensive analysis of the market including Porter’s and SWOT analysis

·         Complete identification and analysis of key industry dynamics including drivers, restraints, raw material trends and buyer behavior

·         The study provides technology landscape and regulatory trends for building strategy

·         Global and regional market estimates and forecast on volume and revenue basis for multiple market segments

·         Detailed competitive landscape of the market, with profiles of key companies

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin : https://www.linkedin.com/company/hexa-research 

eClinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 | Hexa Research

The global eClinical solutions market is anticipated to exceed USD 13 billion by 2024. The major growth driving factors include a rise in the R&D activities by various pharma and biopharma companies, growing application of software solutions in medical trials, rising government funding for promoting clinical research programs, increasing consumer base, and so on. In addition to this, rising outsourcing of medical trials to Contract Research Organization (CROs), growing medical research programs in various Asian countries along with the development of low-cost modules are also projected to boost the market growth.

However, high implementation prices, the lack of skilled labor & awareness about clinical data sciences software are likely to hinder the growth of the market in the near future. The global market is divided into products and regions.

Browse Details of Report@https://www.hexaresearch.com/research-report/eclinical-solutions-market

The products sector includes Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (ECOA), Clinical Data Management Systems (CDMS), Randomization and Trial Supply Management (RTSM), Safety Solutions, Clinical Data Integration Platforms, Clinical Trial Management Systems (CTMS), and Electronic Trial Master File (e-TMF). The ECOA sector is projected to experience the maximum growth rate over the forecast period (from 2016 to 2024), while the CDMS and EDC sectors are anticipated to dominate the market through the year 2016.

Regionally, the global eClinical solutions market is segregated as Latin America, North America, Asia-Pacific, Europe, and the Middle East & Africa. As of 2016, the North American market is expected to dominate the global market occupying the largest industry share. The major factor for this growth is the growing number of ongoing medical trials in the region. Some other factors include the rising government support for clinical trials, extensive Research & Development activities resulting in the production and launch of innovative products, and the increasing occurrences of lifestyle diseases. The APAC region is also likely to witness a rapid growth over the next few years. The rising participation of developing countries in the clinical trials is said to augment the market growth during the estimated years.

The key companies operating in the global eClinical solutions market are Parexel International Corp.; ERT inc.; Oracle Corp.; BioClinica; DataTrak International Inc.; Medidata Solution Inc.; Merge Health Inc.; CRF Health Inc.; OmniComm Systems Inc.; and eClinical Solutions LLC.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin : https://www.linkedin.com/company/hexa-research

Neurostimulation Devices Market Research Report - Industry Analysis and Forecast to 2020 | Hexa Research

A recent study by Hexa Research revealed that limited range of treatment choices relating to medical conditions like epilepsy, Alzheimer’s disease, Parkinson’s disease, migraine headaches, etc. is one of the key drivers of the global neurostimulation devices market. An upcoming application area is the use of neurostimulation devices for therapeutic purposes, commonly referred to as neuromodulation. 

The neurostimulation devices market is benefitting from technological advancements like the transdermal neuromodulation technology by Neurowave Medical Technologies and MRI safety-enabled devices by Medtronics, Inc. Rising elderly populace - a high risk demographic for Parkinson’s and Alzheimer’s, is also driving market growth. Accelerated demand for neurostimulation devices in the future years is expected to result from untapped market opportunities in emerging economies of Asia as well as Latin America and the growing number of externally funded clinical programs for development of new products.

Browse Details of Report@https://www.hexaresearch.com/research-report/neurostimulation-devices-industry/

Hexa Research identifies spinal cord stimulation devices, vagus nerve stimulation devices, gastric electric stimulation devices, deep brain stimulation devices, and sacral nerve stimulation devices to be the key product segments in the neurostimulation devices market. Spinal cord stimulation devices, with a contribution of more than half to the total revenues, were the dominant product segment in 2012.

Pain management proved to be the largest application of neurostimulation devices in 2012 and contributed more than 65% to the total demand that year. This was chiefly due to high incidence of conditions characterized by chronic pain and notable therapeutic effects offered by neurostimulation devices.

While North America contributed around 64% to the total revenues in 2012, Asia Pacific is likely to grow the fastest in future. Fast-developing economies like India and China will result in the Asia Pacific neurostimulation devices market growing at CAGR higher than 16% from 2013 to 2020.

Hexa Research observes that the neurostimulation devices industry exhibits outsourcing of expensive manufacturing activities. This enables industry participants to achieve cost efficiency and better profitability. Key industry players include Boston Scientific Corporation, Cyberonics, Medtronic Inc., and St. Jude Medical.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on LinkedIn: https://www.linkedin.com/company/hexa-research 

Bio-electronics And Biosensors Market Analysis, Size, Share, Growth and Forecast, 2016 to 2024 | Hexa Research

Projected to grow at a CAGR of above 10%, Bio-electronics & Biosensors market is anticipated to witness a significant growth over forecast period owing to the increase in demand for tracking devices and diagnostics, such as cardiac pacemakers, glucose level in blood and other implantable medical devices.

The increasing prevalence of diseases is also expected to drive the market growth over the forecast period. As, according to statistics released by the International Diabetes Federation, one in 12 people worldwide are diagnosed with diabetes. It is expected that this increase in the prevalence of diabetes worldwide and the need to constantly measure the level of glucose in the blood to drive market growth of biosensors & bio-electronics. Bio-electronics involves applications of principles of electronic engineering to biology. It helps to come up with advanced concepts, improves knowledge across molecular to organ systems and helps in developing enhanced medical devices.

It is expected that the technological advancement in biosensors would contribute to future market growth of biosensors. For example, the biosensor E-skin which is a wearable medical device that can measure blood pressure and heart rate. Also, the paper diagnostic machines the size of a credit card that gives instant reading on saliva and blood samples. Moreover, it is expected that the deterioration of environmental conditions continuously to improve market penetration rates, on account of its advantages over conventional biosensors analytical methods.

Browse Details of Report@

https://www.hexaresearch.com/upcoming-research/bio-electronics-biosensors-market

Furthermore, emergence of nanotechnology or nanobiosensors such as Fluid-Screen which is a size of quarter, uses very small nanosensors capable of detecting pathogens in water for quality screening and bacterial infection in blood is also to fuel the market over next eight years. Also, the increasing demand for home based Poc devices such as biosensor devices used to measure blood pressure, heart rate and diabetes anytime at home are to have a positive impact on the market.

However, slow rate of commercialization owing to number of factors such as sensitivity, readout times, life span of a molecule, miniaturization and cost pose a threat to this industry. Also, high cost in research & development and reluctance towards adopting a new treatment practices is to pose a challenge to bio-electronics and biosensors market.  Moreover, emerging market in developing countries and use of biosensors in non-medical applications such as food industry, environmental monitoring and biodefense provide opportunities to bio-electronics and biosensors market. The biosensors are used to detect pathogens on food surfaces, bacteria in water and even explosives in different places.

The bio-electronic and biosensor market can be segmented on the basis of product, technology and application. On the basis of application, the market consists of point-of-care, home diagnostics, research labs, biodefense, environmental monitoring and food safety. The point-of-care application dominated the industry in the recent past owing to increased diseases and capability of providing real-time health monitoring. The home diagnostics application is also to witness significant growth over the forecast period on account of increasing diabetic patients and their need to test the level of insulin 2-3 times a day.

On the basis of product the market can be divided into wearable and non-wearable biosensors. Wearable biosensors further include wrist wear, eye wear, foot wear, neck wear and body wear. For example, Vital Connect introduced HealthPatch MD biosensor which is chest wearable capable of detecting heart rate, single lead ECG, respiratory rate, posture and skin temperature. Wearable biosensors are to witness a significant growth over the forecast period owing to its lost cost, easy access and miniaturization.

On the basis of technology, the market includes electrochemical, piezoelectric, optical and thermal biosensors. Optical biosensors are to witness significant growth over the forecast period owing to environmental monitoring and its capability to differentiate between the contaminants present in the environment. 

North America is anticipated to grow over the forecast period owing to large number of applications in health sectors and in turn increasing demand. The proliferation of various serious diseases due to the unhealthy living style, presence of R&D units and increased adoptability of medical devices by patients and doctors are to drive industry growth in the next eight years. Asia-Pacific market is to witness a significant growth over the forecast period on account of the improvement of health infrastructure and rapid economic growth.

Major Players in this industry are Abbott Point of Care Inc., AgaMatrix, Inc., F. Hoffmann-La Roche Ltd., LifeSensors, Inc., Siemens Healthcare, Nova Biomedical Corporation, Bayer AG, LifeScan Inc., Medtronic Inc., Pharmaco-Kinesis Corporation and Universal Biosensors. These companies are expanding to encompass advanced products and new segments.

In May, 2016, Siemens Healthcare announced the acquisition of Neo New Oncology to expand in molecular diagnostics and therapeutic as well as add offerings in managed services, consulting and digital services.

 Browse Related Category Market Reports @

https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin: https://www.linkedin.com/company/hexa-research 

Optical Coherence Tomography (OCT) Market Size, Industry Trends And Forecast, 2013 - 2019 | Hexa Research

Optical coherence tomography market is a non-invasive medical procedure applied to image various components of biological tissues like structural information, polarization sensitivity and blood flow. It does not require physical contact with the patient and is a safe and effective diagnostic technique.

According to a recent study conducted by Hexa Research the usage of this technology is distinct from other imaging techniques like magnetic resonance imaging and ultrasound imaging. Growing preference for non-invasive medical procedures and widespread global prevalence of ophthalmic diseases are the key demand drivers for optical coherence tomography market. Growing cases of skin and neurological disorders and rising awareness levels are also important contributors to growth. WHO estimates that the share of geriatrics which was 13% of the total global population in 2010 will rise to 53% 2020. Rising number of geriatrics will also propel demand for the global optical coherence tomography market.

Browse Full Report @ https://www.hexaresearch.com/upcoming-research/optical-coherence-tomography-industry

Hexa Research notes that ongoing technological research and resource deployments in new product development are expected to benefit future market growth. Opportunities also exist due to growing penetration of niche technologies like high resolution optical coherence tomography in areas like dermatology and gastroenterology. Furthermore, the market is characterized by high unmet medical needs and a steadily improving healthcare infrastructure, especially in emerging regions like Asia and Latin America.

North American optical coherence tomography industry features higher adoption of advanced imaging modalities and heavy spending from the government. These factors are likely to augment future demand. Therefore, North America is expected to retain market leadership in the coming years. Asia Pacific will experience fastest growth in the forthcoming years, mainly due to immense market potential in emerging countries of the region.

Hexa Research enlists Carl Zeiss, Heliotis AG, Michelson Diagnostics, Agfa Healthcare, etc. as the key market players in the global optical coherence tomography industry. Main application segments are ophthalmology, dermatology, cancer detection, dentistry, intra surgery for tumor margining and gastroenterology. The products can be segmented into time domain and polarization sensitive, full-field and optical delay and fourier-domain and time encoded optical coherence tomography.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin : https://www.linkedin.com/company/hexa-research

Doxorubicin Market Analysis, Size, Share, Growth, Industry Trends and Forecast Report up to 2024 - Hexa Research

Doxorubicin is an anti-cancer chemotherapy drug. It is an intravenous injection through a central or peripheral venous line. No pill form of this drug is available in the market. Doxorubicin market is expected to witness a significant growth in the developed regions due to the multiple incidences of cancer occurrence in these regions. According to World Health Organization (WHO), in 2012, 14.1 million new cancer cases were detected worldwide.

Doxorubicin is an anthracycline chemotherapy drug that slows down the growth of cancer cells which is one of the primary reasons of its demand globally.. Four most common cancers worldwide are lung cancer, prostate cancer, female breast and bowel. Doxorubicin drug provides chemotherapy treatment for all four cancers which is anticipated to drive the industry in next eight years. Early diagnosis led to the longer duration of treatment which in turn increases the demand for doxorubicin drug. Increasing effectiveness of drug therapies are contributing to the higher spending on drugs for cancer care. Moreover, various government initiatives for controlling cancer and increasing its awareness through  governmental organizations such as Cancer Prevention And Control Research Network (CPCRN )and National Cancer Institute is creating to have a positive impact on the anti-cancer drug. Increased alcohol consumption, usage of tobacco coupled with lack of physical activity and unhealthy diet are considered to be main risk factors of cancer worldwide. According to WHO estimates, the mortality rate worldwide was 8.2 billion in 2012 and is expected to rise by about 70% in the near future. Due to aforementioned reasons, anti-cancer drug market revenues are anticipated to increase in the near future

Browse Detail Report@

https://www.hexaresearch.com/upcoming-research/doxorubicin-market

Media is also playing an important role in spreading awareness about various diseases and related drugs. Consumer awareness of these drugs is expected to have a positive impact on the doxorubicin market. Support from non-profit organizations and regional government in UK on approval of drugs is anticipated to drive the market during the forecast period.

However, Doxorubicin therapy can cause a risk of developing leukemia and tumor lysis syndrome which can further lead to kidney failure is expected to act as a roadblock for the growth of doxorubicin market. This drug also has adverse effects and can cause skin rashes, itchy sensation, can lead patient feel short of breath, swelling of face, feeling dizzy and stomach ache. Moreover, it can cause extensive tissue damage and can develop dizziness among consumer. High treatment cost poses a challenge to this market. Also, pharmaceutical industries significantly rely on the R&D initiatives. Pharmaceutical agencies are focusing on new medicines in order to cater to the customer needs which may poses as a threat to this market in the long run.

The market can be segmented on the basis of cancer type. Doxorubicin treats number of cancers such as acute lymphoblastic leukemia, acute myeloblastic leukemia, bone sarcoma, breast cancer, endometrial cancer, gastric cancer, head and neck cancer, liver cancer, kidney cancer, ovarion cancer, small cell lung cancer, thyroid cancer and transitional cell bladder cancer. Drug used for treating thyroid cancer dominated the market in the recent past on account of growing incidences of thyroid cancer especially in UK.

The U.S. dominated the market in the near past on account approval of doxorubicin products by FDA and increasing number of cancer incidences. Europe is one of the major markets owing to increasing number of deaths due to cancer. Emerging nations such as India and China are anticipated to show a substantial growth rate based on the growing population, cancer incidences and tobacco consumption. Africa is expected to observe a lower growth rate owing to lack of consumer awareness and healthcare infrastructure, and expensive medication.

Key players in this market include Pfizer Inc., Dabur Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd., German Remedies Ltd., Biological E Ltd., Elder Pharmaceuticals Pvt. Ltd., Cipla Ltd., Sun Pharmaceuticals Industries Ltd., Natco Pharma Ltd., Biochem Pharmaceutical Industries Ltd., Pharmacia India Ltd., VHB Life Science Inc., Chandra Bhagat Pharma Pvt. Ltd., GLS Pharma Ltd., and Intas Laboratories Pvt. Ltd. Mergers and acquisitions in this industry is helping acquirer in building technical expertise and hold a library of patents.

In March 2015, Sun Pharmaceuticals Industries Ltd. acquired Ranbaxy Laboratories Ltd. to increase its presence in the global and domestic markets by filling therapeutic gaps in the U.S.

In February 2013, Sun Pharma’s Lipodox (doxorubicin hydrochloride liposome injection) was approved by FDA for the treatment of ovarian cancer in the patients.

Browse Related Category Market Reports@

https://www.hexaresearch.com/research-category/pharmaceuticals-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow us on Linkedin: https://www.linkedin.com/company/hexa-research